113 related articles for article (PubMed ID: 2472225)
1. DNA binding, cytotoxicity and inhibitory effect on RNA synthesis of two new 1-nitro-9-aminoacridine dimers.
Markovits J; Wilmańska D; Lescot E; Studzian K; Szmigiero L; Gniazdowski M
Chem Biol Interact; 1989; 70(1-2):73-87. PubMed ID: 2472225
[TBL] [Abstract][Full Text] [Related]
2. Thiol-dependent inhibition of RNA synthesis in vitro by acridines: structure-inhibition relationships.
Gniazdowski M; Szmigiero L; Wilmańska D
Cancer Lett; 1982 Jan; 15(1):73-9. PubMed ID: 6174208
[TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.
Charmantray F; Demeunynck M; Carrez D; Croisy A; Lansiaux A; Bailly C; Colson P
J Med Chem; 2003 Mar; 46(6):967-77. PubMed ID: 12620073
[TBL] [Abstract][Full Text] [Related]
4. Intercalation model for DNA-cross linking in a 1-nitro-9-aminoacridine derivative, an analog of the antitumor agent "ledakrin" (nitracrine).
Stallings WC; Glusker JP; Carrell HL; Bogucka-Ledóchowska M; Ledóchowski A; Stezowski JJ
J Biomol Struct Dyn; 1984 Dec; 2(3):511-24. PubMed ID: 6400911
[TBL] [Abstract][Full Text] [Related]
5. 32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.
Bartoszek A; Konopa J
Biochem Pharmacol; 1989 Apr; 38(8):1301-12. PubMed ID: 2706021
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide.
Rewcastle GW; Atwell GJ; Chambers D; Baguley BC; Denny WA
J Med Chem; 1986 Apr; 29(4):472-7. PubMed ID: 3959026
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activity and DNA interaction of anilinoacridine and bithiazole peptide derivatives related to the anti-tumor drugs m-AMSA and bleomycin.
Morier-Teissier E; Bailly C; Bernier JL; Houssin R; Helbecque N; Catteau JP; Colson P; Houssier C; Hénichart JP
Anticancer Drug Des; 1989 Jun; 4(1):37-52. PubMed ID: 2474298
[TBL] [Abstract][Full Text] [Related]
8. The intercalative DNA binding and antitumor activity of some bis-acridines related to nitracrine.
Acheson RM; Taylor GN; Waring MJ; Haylock S; Abel G
Chem Biol Interact; 1985 May; 53(3):371-5. PubMed ID: 4006013
[No Abstract] [Full Text] [Related]
9. Acridine dimers: influence of the intercalating ring and of the linking-chain nature on the equilibrium and kinetic DNA-binding parameters.
Markovits J; Garbay-Jaureguiberry C; Roques BP; Le Pecq JB
Eur J Biochem; 1989 Mar; 180(2):359-66. PubMed ID: 2924770
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of RNA synthesis in vitro by 9-aminoacridine carboxamide antitumor agents. Effects on overall RNA synthesis and synthesis of the initiating dinucleotide.
Piestrzeniewicz MK; Czyz M; Denny WA; Gniazdowski M
Acta Biochim Pol; 1990; 37(2):299-307. PubMed ID: 1705740
[TBL] [Abstract][Full Text] [Related]
11. DNA intercalating compounds as potential antitumor agents. 2. Preparation and properties of 7H-pyridocarbazole dimers.
Pelaprat D; Delbarre A; Le Guen I; Roques BP; Le Pecq JB
J Med Chem; 1980 Dec; 23(12):1336-43. PubMed ID: 7452686
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
Mazerska Z; Lukowicz J; Konopa J
Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative Effect of Novel Aminoacridine-based Compounds.
Munder A; Moskovitz Y; Redko B; Levy AR; Ruthstein S; Gellerman G; Gruzman A
Med Chem; 2015; 11(4):373-82. PubMed ID: 25524547
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
15. Some properties of the irreversible complexes of nitracrine (ledakrin, C-283) with polynucleotides.
Gniazdowski M; Ciesielska E; Szmigiero L
Chem Biol Interact; 1981 Mar; 34(3):355-66. PubMed ID: 6161711
[TBL] [Abstract][Full Text] [Related]
16. Complexes of nitracrine with DNA. Stoichiometry of binding.
Szmigiero L; Gniazdowski M
Arzneimittelforschung; 1981; 31(11):1875-7. PubMed ID: 7198467
[TBL] [Abstract][Full Text] [Related]
17. Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells.
Woynarowski JM; McNamee H; Szmigiero L; Beerman TA; Konopa J
Biochem Pharmacol; 1989 Nov; 38(22):4095-101. PubMed ID: 2557039
[TBL] [Abstract][Full Text] [Related]
18. Interactions of some nitro-derivatives of substituted 9-aminoacridine with DNA.
Filipski J; Marczyński B; Sadzińska L; Chalupka G; Chorazy M
Biochim Biophys Acta; 1977 Sep; 478(1):33-43. PubMed ID: 196646
[TBL] [Abstract][Full Text] [Related]
19. Potential antitumor agents. 37. Organophosphorus derivatives of 9-anilinoacridine.
Rewcastle GW; Baguley BC; Cain BF
J Med Chem; 1982 Oct; 25(10):1231-5. PubMed ID: 7143362
[TBL] [Abstract][Full Text] [Related]
20. Potential antitumor agents. 43. Synthesis and biological activity of dibasic 9-aminoacridine-4-carboxamides, a new class of antitumor agent.
Atwell GJ; Cain BF; Baguley BC; Finlay GJ; Denny WA
J Med Chem; 1984 Nov; 27(11):1481-5. PubMed ID: 6492078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
